BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/26/2025 10:27:32 AM | Browse: 2 | Download: 1
 |
Received |
|
2025-07-03 13:11 |
|
Peer-Review Started |
|
2025-07-03 13:12 |
|
First Decision by Editorial Office Director |
|
2025-07-29 09:33 |
|
Return for Revision |
|
2025-07-29 09:33 |
|
Revised |
|
2025-08-11 15:52 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-20 23:18 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-21 06:32 |
|
Articles in Press |
|
2025-11-21 06:32 |
|
Edit the Manuscript by Language Editor |
|
2025-11-24 02:14 |
|
Typeset the Manuscript |
|
2025-12-18 02:17 |
|
Publish the Manuscript Online |
|
2025-12-26 10:27 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Severe hyperlipidemia associated with drug-induced cholestatic liver disease: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Meng-Jiao Xu, Xin Wei, Yao Lu, Lei Sun, Yao Xie and Ming-Hui Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Beijing Municipal Health Commission High-Level Public Health Technical Personnel Construction Project |
discipline leader-03-26 |
| Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support |
ZLRK202301 |
| Beijing Hospitals Authority “Peak” Talent Training Program |
DFL20241803 |
| The National Key Research and Development Program |
2023YFC2306901, 2023YFC2308105 |
|
| Corresponding Author |
Ming-Hui Li, Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshun East Street, Chaoyang District, Beijing 100015, China. wuhm2000@sina.com |
| Key Words |
Drug-induced liver injury; Cholestasis; Hyperlipidemia; Glucocorticosteroid; Case report |
| Core Tip |
Hyperlipidemia is closely associated with the development of multiple diseases and is widely recognized as a major risk factor for cardiovascular disease. In clinical settings, drug-induced cholestatic liver disease can increase cholesterol and triglyceride levels in the blood, a condition known as secondary hyperlipidemia. Furthermore, lipid overload can exacerbate hepatic oxidative stress. Therefore, accurate recognition and management of hyperlipidemia are crucial for systemic health and the functioning of multiple organs. |
| Publish Date |
2025-12-26 10:27 |
| Citation |
Xu MJ, Wei X, Lu Y, Sun L, Xie Y, Li MH. Severe hyperlipidemia associated with drug-induced cholestatic liver disease: A case report. World J Hepatol 2025; 17(12): 111414 |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i12/111414.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i12.111414 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
